Patent classifications
C12Y102/01024
MESSENGER RNA TREATMENT FOR SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY
Provided herein is an mRNA therapy composition and method for use thereof to treat succinic semialdehyde dehydrogenase (SSADH) deficiency (SSADHD). ALDH5A1-coding mRNA is formulated and encapsulated in lipid nanoparticles (LNPs) or micelles, then administered to subjects with SSADHD to effect expression of ALDH5A1, restoring SSADH activity and resulting in neurometabolic improvement.
HIGH YIELD ROUTE FOR THE PRODUCTION OF COMPOUNDS FROM RENEWABLE SOURCES
Provided herein are methods, compositions, and non-naturally occurring microbial organism for preparing compounds such as 1-butanol, butyric acid, succinic acid, 1,4-butanediol, 1-pentanol, pentanoic acid, glutaric acid, 1,5-pentanediol, 1-hexanol, hexanoic acid, adipic acid, 1,6-hexanediol, 6-hydroxy hexanoic acid, -Caprolactone, 6-amino-hexanoic acid, -Caprolactam, hexamethylenediamine, linear fatty acids and linear fatty alcohols that are between 7-25 carbons long, linear alkanes and linear -alkenes that are between 6-24 carbons long, sebacic acid and dodecanedioic acid comprising: a) converting a C.sub.N aldehyde and pyruvate to a C.sub.N+3 -hydroxyketone intermediate through an aldol addition; and b) converting the C.sub.N+3-hydroxyketone intermediate to the compounds through enzymatic steps, or a combination of enzymatic and chemical steps.
Method for producing polybutylene terephthalate
The present invention aims to provide a method for producing polybutylene terephthalate (PBT) with an excellent color using biomass-derived 1,4-butanediol (BG). The invention relates to a method for producing PBT comprising a step of subjecting a diol component containing raw material 1,4-BG having a nitrogen content of 0.01 to 50 ppm by mass and a dicarboxylic acid component to esterification or ester-exchange reaction, and a polycondensation reaction step for obtaining PBT from the reactant, wherein the content of gamma butyrolactone in the raw material 1,4-BG is 1 to 100 ppm by mass.
BIOCHEMICAL PATHWAY FOR THE PRODUCTION OF TULIPALIN A VIA ITACONIC ACID
Disclosed herein are methods for producing tulipalin A (-methylene--butyrolactone), recombinant cells or organisms for producing tulipalin A, enzymes needed for producing tulipalin A, and nucleic acids for expression of those enzymes.